CureSight-CS100— 510(k) K221375
Substantially EquivalentNovasight , Ltd.
FDA 510(k) clearance K221375 for CureSight-CS100, Substantially Equivalent on 2022-09-29. Applicant: Novasight , Ltd.. Device class: 2.
Clearance details
- Applicant
- Novasight , Ltd.
- Product code
- Code QQU
- Device class
- Class 2
- Regulation
- 21 CFR 886.5500
- Advisory panel
- Ophthalmic
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Airport City, IL
Recent devices under product code QQU
view allData sourced from openFDA. This site is unofficial and independent of the FDA.